Delivery Order SPE2DB20D9761-SPE2DB24FB3KE
Award Date
5/10/24
Potential Completion Date
6/3/24
Potential Value
$1.4K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of EXPAREL 133 MG/10 ML VIAL 10ML. The delivery order, valued at $5,711.28, has a completion date of May 30, 2024 and was awarded on May 8, 2024. DMS Pharmaceutical Group holds a significant Indefinite Delivery Contract (IDC) with the DLA, valued up to $499,999,999, that allows the agency to issue delivery orders for...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide EXPAREL 266 MG/20 ML VIAL 20ML. This $49,744.40 delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) with DMS Pharmaceutical Group to fulfill recurring pharmaceutical supply needs for military health facilities worldwide. The IDC, which runs through December 31, 2025, allows the DLA...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the delivery of EXPAREL 1.3% 20ML 10S. The contract, valued at $14,923.32, has a completion date of May 16, 2024 and is not set aside. DMS Pharmaceutical Group holds a larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program to provide a wide range of pharmaceutical products...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the provision of EXPAREL 133 MG/10 ML VIAL 10ML. The contract has a ceiling value of $4,521.66 and an ultimate completion date of April 14, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, valued at $499,999,999...
The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide EXPAREL 133 MG/10 ML VIAL 10ML. The delivery order, valued at $11,422.56, has a completion date of February 5, 2024. This award is not associated with a set-aside program. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler that holds multiple contracts and indefinite delivery vehicles with DLA to supply a wide range of...
The Defense Logistics Agency (DLA) awarded a Delivery Order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the provision of EXPAREL 266 MG/20 ML VIAL 20ML. The firm-fixed-price contract has a potential value of $9,948.88 and a completion date of March 25, 2024. This Delivery Order contract is part of a larger Indefinite Delivery Vehicle (IDV) contract, contract 4600082013 under the SPE2DB program, valued at up to $4,999,999 through the end of 2025. Under this IDV,...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,145.70 contract is for the supply of EXPAREL 133 MG/10 ML VIAL 10ML, a pharmaceutical product, to support the recurring medical supply needs of military health facilities. This delivery order is placed under DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery...
The Defense Logistics Agency (DLA) awarded a $9,948.88 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is for the supply of EXPAREL 266 MG/20 ML VIAL 20ML, a specialized pharmaceutical product, with a period of performance through December 2, 2024. This delivery order is placed against DMS Pharmaceutical Group's existing $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of the pharmaceutical product EXPAREL 266 MG/20 ML VIAL 20ML. The fixed-price contract has a ceiling value of $7,461.66 and a completion date of April 8, 2024. This delivery order is part of a larger indefinite delivery contract (SPE2DB) that DMS Pharmaceutical Group holds with the DLA, valued at up to $4,999,999 through the end of 2025, for the...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide EXPAREL 133MG/10ML pharmaceutical products. The $2,855.64 contract was awarded on March 22, 2024 and has an ultimate completion date of April 8, 2024. This order is placed against DMS Pharmaceutical Group's indefinite delivery contract 4600082013 with DLA under the SPE2DB program, which has a ceiling value of up to $4,999,999...